Mediphage Bioceuticals Company
Developing safe and effective gene delivery platforms to unlock the therapeutic power of personalized, redoseable genetic medicine.
Headquarters:
Canada
Funding Status:
Seed
Estimated Revenue:
$1M to $10M
Technology:
Rare Genetic Disorders
Founded Date:
2016
Industry:
Gene Therapy